ARQT peer analysis
Arcutis (ARQT) against its competitors: price, today's move, 1-year return and market value side by side.
ARQT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.78 | -4.79% | 51.81% | $615.29M |
| ALDX Aldeyra Therapeutics | $0.56 | -14.99% | -88.86% | $33.80M |
| EVMN Evommune | $6.73 | -1.17% | – | – |
| SLGL Sol-Gel | $68.35 | -0.45% | 84.73% | $223.78M |
| TTRX Turn Therapeutics | $10.43 | -2.71% | 99.05% | – |
| ARQT Arcutis | $31.25 | -2.54% | 25.42% | $4.03B |
- ARQT's peers: ACRS (Aclaris Therapeutics), ALDX (Aldeyra Therapeutics), EVMN (Evommune), SLGL (Sol-Gel), TTRX (Turn Therapeutics).
Updated 2026-11-02 23:13 UTC